Structural Changes of Apolipoprotein A-I Caused by Hydroxyethyl Starch 130/0.4 Reveals Potential Toxic Mechanisms
- PMID: 40884741
- DOI: 10.1007/s10930-025-10283-8
Structural Changes of Apolipoprotein A-I Caused by Hydroxyethyl Starch 130/0.4 Reveals Potential Toxic Mechanisms
Abstract
6% hydroxyethyl starch (HES 130/0.4) is frequently employed to address hypovolemia, ensuring sufficient organ perfusion and oxygen transport. The effects on Apolipoprotein A-I (ApoA-I) were examined at three temperatures-280, 295, and 310 K-through several spectroscopic techniques to explore its possible interaction with the predominant protein in veins. The experimental findings indicated that HES 130/0.4 efficiently extinguished the intrinsic fluorescence of APOA-I. We also assessed the binding sites, binding constant, and thermodynamic parameters, which indicated that HES 130/0.4 can spontaneously associate with APOA-I via hydrogen bonds and van der Waals interactions (ΔG = - 1.93 × 104 J·mol-1, ΔH = - 5.63 × 104 J mol⁻1, and ΔS = - 119 J mol⁻1 K⁻1) with a single binding site and week binding forces (n = 1.03 and KA = 1.78 × 103 M-1) at body temperature. Moreover, the structure of APOA-I was significantly altered in the presence of HES 130/0.4. Blood Ca2+ and Fe3+ will diminish the storage duration. The study provides accurate and thorough foundational data to clarify the binding mechanisms of HES 130/0.4 with APOA-I in vitro, which may help the comprehension of its impact on protein function and toxic mechanism during transit and distribution in the bloodstream.
Keywords: Apolipoprotein; Hydroxyethyl starch 130/0.4; Spectroscopy.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Volume expanders for the prevention of ovarian hyperstimulation syndrome.Cochrane Database Syst Rev. 2016 Aug 31;2016(8):CD001302. doi: 10.1002/14651858.CD001302.pub3. Cochrane Database Syst Rev. 2016. PMID: 27577848 Free PMC article.
-
Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function.Cochrane Database Syst Rev. 2013 Jul 23;2013(7):CD007594. doi: 10.1002/14651858.CD007594.pub3. Cochrane Database Syst Rev. 2013. PMID: 23881659 Free PMC article.
-
The structure of the apolipoprotein A-I monomer provides insights into its oligomerisation and lipid-binding mechanisms.J Mol Biol. 2025 Aug 13:169394. doi: 10.1016/j.jmb.2025.169394. Online ahead of print. J Mol Biol. 2025. PMID: 40816717
-
Active body surface warming systems for preventing complications caused by inadvertent perioperative hypothermia in adults.Cochrane Database Syst Rev. 2016 Apr 21;4(4):CD009016. doi: 10.1002/14651858.CD009016.pub2. Cochrane Database Syst Rev. 2016. PMID: 27098439 Free PMC article.
References
-
- Hartog CS, Kohl M, Reinhart K (2011) A systematic review of third-generation hydroxyethyl starch (HES 130/0.4) in resuscitation: safety not adequately addressed. Anesth Analg 112:635–645 - PubMed
-
- Skhirtladze K, Base E, Lassnigg A, Kaider A, Linke S, Dworschak M, Hiesmayr M (2014) Comparison of the effects of albumin 5%, hydroxyethyl starch 130/0.4 6%, and ringer’s lactate on blood loss and coagulation after cardiac surgery. Br J Anaesth 112:255–264 - PubMed
-
- Glover PA, Rudloff E, Kirby R (2014) Hydroxyethyl starch: a review of pharmacokinetics, pharmacodynamics, current products, and potential clinical risks, benefits, and use. J Vet Emerg Crit Care 24:642–661
-
- Kammerer T, Hulde N, Speck E, Hübner M, Crispin A, Zwissler B, Conzen P, von Dossow V, Schäfer ST, Hofmann-Kiefer K (2019) Effects of balanced hydroxyethyl starch 6%(130/0.4) and albumin 5% on clot formation and glycocalyx shedding: subgroup analysis of a prospective randomized trial. Thromb Res 183:111–118 - PubMed
-
- Obici L, Franceschini G, Calabresi L, Giorgetti S, Stoppini M, Merlini G, Bellotti V (2006) Structure, function and amyloidogenic propensity of apolipoprotein AI. Amyloid 13:191–205 - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous